Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Obeticholic Acid vs Vitamin E in NAFLD
NCT07104786Phase 2Completed
- Sponsor
- King Edward Medical University
- Start
- Aug 2023
- Primary completion
- Nov 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of obeticholic acid in non-alcoholic fatty liver disease (NAFLD), sponsored by King Edward Medical University. Started Aug 2023; status: completed.
02
Drugs
obeticholic acid
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT07104786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07104786.